Calamos Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,954
| Closed | -$735K | – | 228 |
|
|
2017
Q4 | $735K | Buy |
1,954
+460
| +31% | +$173K | 0.1% | 139 |
|
|
2017
Q3 | $668K | Buy |
+1,494
| New | +$668K | 0.09% | 158 |
|
|
2015
Q1 | – | Sell |
-4,479
| Closed | -$1.84M | – | 257 |
|
|
2014
Q4 | $1.84M | Sell |
4,479
-1,187
| -21% | -$487K | 0.53% | 68 |
|
|
2014
Q3 | $2.04M | Buy |
5,666
+30
| +0.5% | +$10.8K | 0.59% | 53 |
|
|
2014
Q2 | $1.59M | Sell |
5,636
-175
| -3% | -$49.4K | 0.45% | 87 |
|
|
2014
Q1 | $1.75M | Buy |
5,811
+1,417
| +32% | +$426K | 0.52% | 83 |
|
|
2013
Q4 | $1.21M | Buy |
4,394
+1,540
| +54% | +$424K | 0.37% | 98 |
|
|
2013
Q3 | $893K | Buy |
2,854
+88
| +3% | +$27.5K | 0.29% | 107 |
|
|
2013
Q2 | $622K | Buy |
+2,766
| New | +$622K | 0.22% | 127 |
|